Delivery Order SPE2DB22D2007-SPE2DB24FJ1ZV
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $3,132.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCl 3 mg tablets, a medication used to treat mental health conditions. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,403.33, is for the delivery of Doxepin Hydrochloride 3 mg tablets in 30-count packages. The award is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, SPE2DB20D1051|SPE2DB24FD6KS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,430.68 firm fixed-price delivery order is for 4,563,172,295 units of the medication Doxepin HCL 3 mg tablets. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023. There was no set-aside designation for this contract....
- This federal contract award, valued at $4,389.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Doxepin Hydrochloride 3 mg tablets. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $3,661.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,855,860 units of Doxepin Hydrochloride 6 mg tablets, with a period of performance through January 8, 2025. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,430.46 firm fixed-price delivery order is for the supply of Doxepin HCL 3 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation,...
- This federal contract award with ID SPE2DB22D3004|SPE2DB24FQN02 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 3 mg doxepin HCL tablets, with a ceiling value of $2,475.66 and a completion date of May 30, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Doxepin HCL 3 mg tablets. The fixed-price, firm-fixed delivery order has a ceiling value of $2,261.61 and an ultimate completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVTGG, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,150.50 and a completion date of February 3, 2025. The award is for the supply of 4567118600 Doxepin HCL 3 mg tablets in packages of 30. The contract is not designated as a set-aside and represents a placement under...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB24FPP67, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,881,521 units of the pharmaceutical drug Doxepin HCL 3 mg tablet, with a ceiling value of $2,853.05. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is March 7, 2024. The contract is not designated as a set-aside...